MedTrace Logo

Pediatric Postoperative Analgesia With Quadratus Lumborum Block(QLB) And Dexamethasone As An Adjuvant To Bupivacaine.

NCT04963816 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2022-02-03

No results posted yet for this study

Summary

Studying the post-operative analgesic effect of dexamethasone as an adjuvant to bupivacaine giving intravenously and locally with ultrasound guided quadratus lumborum block(QLB) in pediatrics undergoing abdominal surgeries

Conditions

  • Post Operative Pain
  • Quadratus Lumborum Block
  • Pediatric
  • Abdominal Surgery

Interventions

PROCEDURE

ultrasound guided quadratus lumborum block

Ultrasound guided quadratus lumborum block will be done to all groups using curved array transducer 5\_2 MHz with the patient in supine position and the block will be done by anterior approach

DRUG

Dexamethasone Phosphate 4 MG/ML Injectable Solution intravenously

Using dexamethasone as an adjuvant to bupivacaine in ultrasound guided quadratus lumborum block which will be given intravenously in group A

DRUG

Bupivacaine Injection

Bupivacaine will be given to all groups locally with QLB

DRUG

Dexamethasone Phosphate 4 MG/ML Injectable Solution locally

Using dexamethasone as an adjuvant to bupivacaine in ultrasound guided quadratus lumborum block which will be given locally in Group B

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • AHMED A SHAMA, MD · Lecturer and consultant of anesthesia and surgical ICU in Tanta University and Faculty of Medicine

  • SHERIF K ARAFA, MD · ASSISTANT PROFESSOR of anesthesia and surgical ICU

  • AMIR A EL SAYED, MD · ASSISTANT PROFESSOR of anesthesia and surgical ICU

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-16
Primary Completion
2021-10-30
Completion
2022-01-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04963816 on ClinicalTrials.gov